Salesforce (NYSE: CRM) has suffered a slew of detractors over the years. Analysts have repeatedly argued that the company is overvalued or would never survive. And yet, here it is, still going strong. Salesforce is a prime example of a company that stuck to its knitting, pursued its vision, and… Read More

AbbVie (NYSE: ABBV) is a $135 billion market cap biotech, making it a “Big Pharma” player. Despite its mammoth size, can this blue-chip drug maker generate outsized growth? Or is AbbVie’s best days behind it? The question takes on added urgency, as the overall stock market gyrates amid growing headline… Read More

At first glance, cannabis company KushCo Holdings (OTC: KSHB) is a pleasant surprise. KushCo appears to be a real business, with growing revenue, and isn’t a penny stock. These qualities help distinguish the company from many marijuana stocks, which are shaky ventures built on hype. KushCo also… Read More

The marijuana industry is in the midst of a classic bubble, reminiscent of the dot.com boom (and bust) of the late 1990s. To be sure, “canna-business” represents one of the greatest investment opportunities you’ll see in your lifetime and certain marijuana stocks offer the potential for exponential gains. However, investors… Read More

The exploding marijuana industry is rife with indirect plays that could be safer bets on growth because they’re involved in non-cannabis niches as well. One such stock is Psychemedics (NSDQ: PMD), a drug-testing firm. Unlike many direct marijuana opportunities, this firm is generating real revenue and profits. The question is… Read More

The marijuana boom is one of the greatest investment frenzies we’ve seen since the dot.com bubble of the late 1990s. Will the “green rush” end the same way, with pain for investors? You can make a lot of money in cannabis, as long as you remain prudent in your stock… Read More

Some of the best marijuana stocks are indirect plays on the industry. If pot goes bust, these firms can still rely on other core operations. GreenGro Technologies (OTC: GRNH) is an indirect marijuana play getting investor attention these days. It’s the sort of company we call “cannabis adjacent.” These are… Read More

Medicine Man Technologies (OTC: MDCL) belongs to a fast-growing marijuana industry niche: consulting and infrastructure services. Medicine Man is not a marijuana producer. The chattering class on Wall Street is infatuated with cannabis stocks. But with Medicine Man, we must raise several caveats. Not only is this a marijuana play,… Read More

The marijuana “green rush” is one of the biggest investment opportunities you can find. But you need to be selective. In this article, we scrutinize AmeriCann (OTC: ACAN) and its prospects for 2019. AmeriCann is a penny stock that has no real revenue or earnings, and plenty of debt. As… Read More

This article will examine a popular topic for many investors: the cheapest blue chip stocks. Blue chips stocks are often considered core holdings in long-term diversified portfolios. The general idea is that these are legacy companies that are “quality investments”, leaders in their field, and have massive market capitalizations. Most… Read More